Trending...
- California's public safety strategy works: Governor Newsom's commitment helps lower crime as new study shows violence prevention saves lives - 109
- Della continues to shine with her new release, Now Breathe featuring Angel Sessions - 104
- Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Verrica Pharmaceuticals Inc. ("Verrica" or "the Company") (NASDAQ: VRCA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between May 28, 2021 and May 24, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before August 5, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Verrica suffered from manufacturing problems at its contract manufacturer's facility during bulk production of its lead product candidate, VP-102. These deficiencies had not been successfully remediated when the Company resubmitted its NDA for VP-102 to the FDA. This failure was likely to impact the chances of regulatory approval for the Company's product candidate. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Verrica, investors suffered damages.
More on The Californer
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Investors who purchased the Company's securities between May 28, 2021 and May 24, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before August 5, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
- Anglepoint Named to Fast Company's 2026 Best Workplaces for Innovators List
- Wavymy New-In Glueless Wig: Blowout Wave 7x5 Glueless Bob Wig
- Gateway Oaks Dental Marks 18th Year in Sacramento by Investing in Modern Dental Technology
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Verrica suffered from manufacturing problems at its contract manufacturer's facility during bulk production of its lead product candidate, VP-102. These deficiencies had not been successfully remediated when the Company resubmitted its NDA for VP-102 to the FDA. This failure was likely to impact the chances of regulatory approval for the Company's product candidate. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Verrica, investors suffered damages.
More on The Californer
- AI Biological Weapon Concerns Increase Focus on CBRN Protection for Private Shelters
- Designer-Inspired Jewellery Gifts: Timeless Pieces for Every Occasion
- Build a Stronger Online Presence with Strategic Web Design & Development
- California: What they are saying: National leaders and lawmakers celebrate Governor Newsom's signature on landmark child safety chatbot and social media laws
- California: Governor Newsom announces appointments 9.10.26
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Filed Under: Business
0 Comments
Latest on The Californer
- Rural California Energy Consultancy Unlocks Remote Sites for Vacation Rentals and ADUs
- Fun and Easy Health Introduces Acupuncture Meridian Wellness Education in Murrieta
- Over 120 Teen Volunteers To Help At 8th Annual Santa Barbara County Farm Day
- Bestselling "Akiti the Hunter" Series Launches National and International Push to Open Libraries
- New Book Brings Decades of Clinical Research to the Addiction Recovery Crisis
- Apple Valley Home Sales Rise 22.0% as Active Listings Fall 20.2%
- Banafsheh Sayyad Offers a Free Sacred Dance Experience to Awaken Focus and Presence
- Long Beach Public Health Laboratory Now Offering Accredited Environmental Lead Testing Services
- French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
- Calder Capital's Growth Continues with Expansion into Southern California
- LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
- Moorpark College Wins 2025-26 Western State Conference Commissioner's Cup
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Refined Wine Accessories for Effortless Entertaining
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- NITE-E-NIGHT: The Future of Gaming Is Live
- Long Beach to Launch Time Capsule Honoring America's 250th Anniversary as Part of 908 Day Celebration
- Long Beach Airport Celebrates Alaska Airlines' Twice-Daily Nonstop Flight Service to Seattle
- Vallejo Home Prices Are Down—So Why Are So Many Homes Still Selling Over Asking?